We are live on ! Find out more
AA

AlphaMark Advisors Portfolio holdings

AUM $231M
1-Year Est. Return 19.98%
This Fund
S&P 500
This Quarter Est. Return
+4.53%
1 Year Est. Return
+19.98%
3 Year Est. Return
+26.38%
5 Year Est. Return
+72.27%
10 Year Est. Return
+180.76%
AUM
$179M
AUM Growth
+$16.8M
Cap. Flow
+$11.5M
Cap. Flow %
6.44%
Top 10 Hldgs %
27.7%
Holding
327
New
30
Increased
62
Reduced
69
Closed
23

Sector Composition

Rank Sector Weight
1 Technology 16.02%
2 Healthcare 13.37%
3 Industrials 11.8%
4 Financials 9.8%
5 Consumer Staples 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WFC icon
276
Wells Fargo
WFC
$261B
$3K ﹤0.01%
56
CELG
277
DELISTED
Celgene Corp
CELG
$3K ﹤0.01%
25
AVNS
278
DELISTED
Avanos Medical
AVNS
$2K ﹤0.01%
43
-25
-37% -$1.16K
BIIB icon
279
Biogen
BIIB
$30B
$2K ﹤0.01%
+4
New +$1.58K
FOLD
280
DELISTED
Amicus Therapeutics
FOLD
$2K ﹤0.01%
146
IDV icon
281
iShares International Select Dividend ETF
IDV
$8.45B
$2K ﹤0.01%
50
-7,225
-99% -$248K
DISCK
282
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$2K ﹤0.01%
82
-608
-88% -$18.4K
MCEP
283
DELISTED
Mid-Con Energy Partners, LP
MCEP
$2K ﹤0.01%
20
VER
284
DELISTED
VEREIT, Inc.
VER
$2K ﹤0.01%
50
BOX icon
285
Box
BOX
$4.37B
$1K ﹤0.01%
+50
New +$940
DNOW icon
286
DNOW Inc
DNOW
$2.58B
$1K ﹤0.01%
31
JD icon
287
JD.com
JD
$44.6B
$1K ﹤0.01%
50
MPC icon
288
Marathon Petroleum
MPC
$92.4B
$1K ﹤0.01%
20
VLO icon
289
Valero Energy
VLO
$92.9B
$1K ﹤0.01%
18
-18
-50% -$1K
NBIS
290
Nebius Group N.V.
NBIS
$48.3B
$1K ﹤0.01%
60
MRO
291
DELISTED
Marathon Oil Corporation
MRO
$1K ﹤0.01%
20
IPXL
292
DELISTED
Impax Laboratories, Inc.
IPXL
$1K ﹤0.01%
+20
New +$796
ARIA
293
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$1K ﹤0.01%
172
DXPE icon
294
DXP Enterprises
DXPE
$2.43B
-9,800
Closed -$495K
EMB icon
295
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
-3,690
Closed -$405K
FAX
296
abrdn Asia-Pacific Income Fund
FAX
$599M
-2,717
Closed -$90K
FENG
297
Phoenix New Media
FENG
$18.3M
-11,333
Closed -$565K
GILD icon
298
Gilead Sciences
GILD
$162B
-39,623
Closed -$3.73M
GSAT icon
299
Globalstar
GSAT
$10.7B
-20
Closed -$1K
HIMX
300
Himax Technologies
HIMX
$2.19B
-2,000
Closed -$16K

Similar funds

AlphaMark Advisors's Q1 2015 Portfolio in Review

As of Q1 2015, AlphaMark Advisors held 327 positions worth $179M, up 10% from $162M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

AlphaMark Advisors deployed $11.5M of net new capital in Q1 2015, opening 30 new positions and adding to 62 existing holdings. Its largest new stake was Xtrackers MSCI EAFE Hedged Equity ETF: 250,351 shares worth $7.5M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Polaris, an estimated $3.4M trimmed.

  • AlphaMark Advisors's largest Q1 2015 buy was Xtrackers MSCI EAFE Hedged Equity ETF: 250,351 shares worth $7.5M.
  • AlphaMark Advisors added most to Fifth Third Bancorp in Q1 2015, an estimated $3.64M increase.
  • AlphaMark Advisors's biggest Q1 2015 reduction was Polaris, cutting an estimated $3.4M.
  • AlphaMark Advisors fully exited Gilead Sciences in Q1 2015, selling an estimated $3.73M.
  • AlphaMark Advisors's ten largest holdings make up 28% of its $179M portfolio in Q1 2015.
  • AlphaMark Advisors opened 30 new positions and closed 23 in Q1 2015.
  • AlphaMark Advisors's portfolio value rose 10% quarter-over-quarter to $179M.

Based on AlphaMark Advisors's 13F filing for Q1 2015, filed 30 Apr 2015.